Home arrow Nachrichten
Home
Airport
Astronomie
Atomuhr
Auto
Cafe' Conzept
D Abgeordnete
Bank
D Bundeskanzler
D Banken
D Bundespräsident
D Grundgesetz
D BGB
D HGB
D StGB
D StVO
D StVZO
D Domain-Host
D Kennzeichen
D Krankenkassen
D PLZ
D Versicherer
D Vorwahlen
Erfinder
Flaggen / Bayrak
Herberge - Waldhaus
Haberler
Hauptstädte
Jobfinder
Kleinanzeigen
Link
Link - HP eintragen
Länderkennzeichen
Milliarder
Nachrichten
Nonillion
Nobel
Nobel Ödülleri
Periodensystem
Rakı
T.C. Atatürk
T.C. ANAYASASI
T.C. Basbakanlar
T.C. Bakanlari
T.C. Cumhur B.
T.C. Genelkurmay B.
T.C. Milletvekilleri
T.C. TBMM BAŞKAN
T.C. Erzincan
T.C. Ahmetli
T.C. Plakalari
T.C. Gazeteler
T.C. Radyolar
T.C. TV
T.C. Üniversiteleri
Türklere vize
Unternehmen/Sirkt.
Wappen / Forslar
Foto Galeri
Kontakt
Suche / Ara
D Zivilprozessordnung
Länder / Ülkeler
Heute: 14
Gestern: 224
Monat: 5340
Total 545511
Seiten Monat 24189
Seiten Total 2400800
Seit: 2007-07-04
Kein Benutzer Online
 
Nachrichten
Forbes - Pharma & Healthcare
Forbes - Pharma & Healthcare

  • Health Secrets Of The World's Oldest People


  • Son Hit With Aging Parent's $93K Nursing Home Bill
    30 states have filial responsibility laws that can throw the burden of support for an indigent family member onto their kids. See what happened to a son when his mother's nursing home sued him for the bill she incurred.

  • Medicare Advantage Reform: Detaching Pay from Performance
    Medicare Advantage (MA) is the “private option” within Medicare. Private health insurers are paid a fixed monthly fee to provide at least the same minimum health benefits to their enrollees as “traditional” fee-for-service (FFS) Medicare, but they also have the ability to offer coordinated care, disease management, phone consultations,

  • Putting the 'Insurance' Back in Health Insurance
    We understand that it would make no sense to buy auto insurance after we’ve already crashed our car. We appreciate that it would be strange to buy homeowner’s insurance after our house has already burned down. And yet, when it comes to health coverage, many of us think that it makes perfect sense to wait until we’re sick to buy health insurance. If we really want to make health insurance affordable and accessible to everyone, we need to go back to basics, and understand all of the government-induced distortions that have made health insurance look nothing like actual insurance.

  • Large Investor Is Putting More Pressure On Allscripts CEO Glen Tullman
    Allscripts is settling in for a fight against one of its largest shareholders. HealthCor Management has sued the electronic health record company to launch a proxy fight, according to Reuters. Last month, the health care investment firm had filed a Notice of Exempt Solicitation with the SEC, asking that Allscripts’ chief executive Glen Tullman resign. Tullman has refused.

  • Studies Probe Effect Of CPAP And Sleep Apnea On Hypertension
    Two studies published in JAMA provide additional but not surprising information about the relationship between obstructive sleep apnea (OSA), hypertension, and the role of continuous positive airway pressure (CPAP).

  • Why The Media 'Can't Handle the Truth' About Accretive Health
    Contributor's Note: We at insideARM.com have been covering the Accretive Health (NASDAQ:AH) "scandal" since Minnesota Attorney General Lori Swanson first published her 100+ page report indicting (in the common, not legal sense of the word) Accretive for badgering patients into making payments and other debt collection abuses --or at least that's what an overwhelming majority of mainstream media outlets heard when they rained down invective in headline after headline on the Illinois-based revenue cycle management company.

  • Who Is Going To Pull Your Plug?
    We have all heard the stories – accidents, sudden illness, or slow decline taking away a person’s capacity to make their health care decisions.  Unfortunately, few people have taken the time to appoint someone as health care surrogate to act on their behalf in these situations and only a handful of people have discussed their wishes with their surrogate.  Today I discuss how to pick your health care surrogate – it definitely requires some thought.

  • Future Medicine: Pills, Platforms, And A Better Band-Aid
    The future of medicine is a vast, opening playing field. If we could invent a magic pill for everything, perhaps we’d never deal with disease and pain again. For now, our human bodies are fallible. And in those fallacies, there is complicated science.

  • Three Health Technology Companies To Watch
    Last week, Towers Watson bought Extend Health, which allows retirees to choose from thousands of private Medicare plans according to their needs, instead of having their employer make the decision. Towers paid $435 million. One of the winners in that transaction was venture capital firm Psilos, which made in five years 10 times its investment in Extend Health—an unusual occurrence in health IT.

  • Imp: READ: Teenagers in 2012 At Increased Risk For Heart Disease
    According to recent data from the National Health and Nutrition Examination Survey study, (NHANES)(http://www.cdc.gov/nchs/nhanes.htm), teenagers growing up today may be at increased risk for heart disease, mainly as the result of excess weight gain which can predispose them to development of metabolic syndrome, which is characterized by central obesity, elevated blood sugar, elevated triglycerides, and reduced HDL cholesterol. Having metabolic syndrome can subsequently predispose one to early development of coronary artery disease, stroke, and type 2 diabetes.

  • What Was The Biggest News You Missed While Watching The Facebook IPO?
    Did we get so obsessed with Facebook that we missed matters of more importance? I think so, not least the significance of the G8 leaders achieving absolutely zero at Camp David. But there was another story that symbolises something about the times we live in.

  • Rivaroxaban For ACS Gets Positive FDA Review, But Questions About ATLAS Trial Conduct Persist
    The FDA will offer generally positive but also highly mixed advice to the FDA's Cardiovascular and Renal Drugs Advisory Committee  when it meets on Wednesday to consider the supplemental new drug application for rivaroxaban (Xarelto, Johnson & Johnson) for use in patients with acute coronary syndrome (ACS) already taking dual antiplatelet therapy. The FDA posted the briefing documents on its website this morning.

  • Is 'Women's Work' Rehumanizing Men?
    Here's a quote that speaks volumes about what kind of work has become associated with men:
    “I.T. is just killing viruses and clearing paper jams all day,” said Scott Kearney, 43, who tried information technology and other fields before becoming a nurse in the pediatric intensive care unit at Children’s Memorial Hermann Hospital in Houston.
    The New York Times reports on the growing phenomenon of men entering into traditionally women's jobs, like dental assistant, nurse, or schoolteacher. It's an eye-opening, if narrow, slice of the broader cultural and economic picture. But the insight behind Scott Kearney's anecdote deserves far more attention than it receives.

  • Stop Signs In Food - The New Secret to Weight Loss
    Scientists are constantly searching for the best ways to help people lose weight. Ways that really work. This week, researchers from Cornell University divulged results from a clever and innovative project that may offer a new secret to successful weight loss.

  • Are Digital Health Companies Aiming Too Low -- Or Is Incremental Improvement Underappreciated?
    Breathless language about changing the world and disrupting the known universe aside, most digital health companies I know aren’t proposing radical new treatments for dreadful diseases – or anything close (see this articulate critique by David Whelan, and this one by Matthew Holt).  At the end of the day, most simply hope to make existing approaches somewhat faster, cheaper, or qualitatively better (i.e. improve the experience of cancer patients, rather than develop novel treatment for the underlying disease).   When you think about it, this isn’t much different than the way the biopharma industry (where I work) is often (derisively) described.

  • Mary R. Kennedy's Death Teaches What United Behavioral Health Forgets: Depression Kills
    Mary Richardson Kennedy, estranged wife of Robert F. Kennedy, Jr., took her own life, leaving behind the sour scent of senseless loss. You and I, as well as her well-heeled Bedford neighbors inconvenienced by helicopters, reporters, and notoriety, are once again reminded of the lesson tragedies like this teach: depression kills. And as I learned from a recent case of mine, it is a lesson the bean counters at United Behavioral Health desperately need to learn but probably won't.

  • What Should Congress Do after the Supreme Court Decision on Obamacare?
    There’s been a bit of a flap in the media this week about what House Republicans are planning to do regarding health care reform once the Supreme Court rules on Obamacare. But the back-and-forth leaves unanswered an important question: given all of the possible SCOTUS scenarios, what should Congress do to optimize the outcome for people with a stake in a functioning health-care system? Let’s examine the possibilities.

  • Mysterious Flaming Rocks in Woman's Pocket Probably Coated in Phosphorus
    Be careful what you pick up at the beach, particularly if the beach is anywhere near Camp Pendleton Marine base.

  • Right Wing Revolts Against GOP Leadership Plans To Keep Popular Parts Of Obamacare
    Remember the whole ‘repeal and replace’ mantra pushed by the GOP leadership in its effort to undo Obamacare?

  • You Know Nothing, Dr. Snow: Why Medicine Can't Be More Like Facebook
    Medicine can never be like Facebook, despite what Matt Herper argues over at Forbes. Perhaps he was just trolling for hits on a day when everyone is thinking about the Facebook IPO, but Herper proposed, with apparently seriousness, that medicine needs to model itself on the tech world in order to match the kind of progress-- and profits-- of a Facebook. But the medical news this week provided ample evidence why this will never happen. Biology is much more complex and resistant than the digital world.

  • Obamacare Activists Prep to be 'Either Celebratory or Agitational' about Supreme Court Decision
    BuzzFeed has obtained a three-page memo from Health Care for America Now, an umbrella group run by labor unions and MoveOn.org. The memo details how the organization and other White House allies plan to adopt alternate messages, depending on whether or not the Affordable Care Act is upheld by the Supreme Court. “Note that many of these can be lined up now, without any additional information about the timing of the specifics of the decision,” the activists write. It’s a free country, of course. But the memo makes for strange reading.

  • Annual Family Healthcare Costs Surge Past $20,000
    Earlier this week and somewhere between the non-stop coverage of Facebook's pending IPO, Milliman Inc. released their annual Medical Index - simply called the Milliman Medical Index (MMI). My first reaction when I saw it was yikes! Just like Steve Martin in the movie Roxanne - I wanted to put another quarter into the vending machine - to return the newspaper. Here's the MMI chart:

  • FDA Approves Generic Clopidogrels As Plavix Loses Patent Protection
    For the second time in the past six months, a cardiology mainstay drug has lost patent protection and gone generic. Today the FDA announced that it had approved several generic versions of clopidogrel (Plavix), the antiplatelet drug that for many years was the second best-selling drug in the world. Last November the best-selling drug of all time, Lipitor (atorvastatin), another cardiology mainstay, went off patent, though it wasn't until earlier this month that multiple generics became available.

  • Brain Twister: Study Showing Good Cholesterol Isn't So Good Could Still Be Good For Good Cholesterol-Boosting Drugs
    A new genetic study in The Lancet is raising questions about whether high-density lipoprotein, the so-called “good cholesterol,” is actually all that good at preventing heart attacks and strokes.

  • Video: Paralyzed Woman Controls Robotic Arm with Her Mind
    From Nature Video:
    Cathy Hutchinson has been unable to move her own arms or legs for 15 years. But using the most advanced brain-machine interface ever developed, she can steer a robotic arm towards a bottle, pick it up, and drink her morning coffee. The interface includes a sensor implanted in Cathy's brain, which 'reads' her thoughts, and a decoder, which turns her thoughts into instructions for the robotic arm. In this video, watch Cathy control the arm and hear from the team behind the pioneering study.
     

  • Large Metaanalysis Finds Statins Effective in Low Risk Patients
    A very large metaanalysis provides strong evidence that the relative reduction in risk of statins is at least as great in low-risk patients as in high-risk patients. The finding, write the authors, provides evidence that expansion of guidelines to lower risk populations should be considered.

  • Are House Republicans Caving in on Repealing Obamacare? Doubtful.
    Politico is reporting that House Republicans are preparing for the possibility that the Supreme Court upholds the law by drafting new legislation. “When the court rules, we’ll be ready,” House Speaker John Boehner (R., Ohio) told the House Republican Conference on Wednesday. But what’s surprising about alleged GOP plans is that they involve preserving significant—and damaging—aspects of the Affordable Care Act, for what appear to be political reasons. I’m not convinced that the story is accurate.

  • Doctors Find Less Need For Abbott's 'Good Cholesterol' Pill
    A year after a major study called into question whether prescribing an Abbott Laboratories’ pill designed to raise levels of good cholesterol protected against heart attacks and strokes, doctors are moving away from prescribing the treatment.


Umfrage
Wie haben Sie uns gefunden?
  
Zur Zeit Online
Aktuell sind 23 Gäste online
Statistics
Besucher: 2081079
Wetter

Deine IP
Dein System:

Deine IP: 38.107.179.240
Dein ISP: 179.240
Domaincheck

Ihre Wunschdomain
Domain: 

Güldag